Matthew Angel

Matthew Angel

Founder presso Exacis Biotherapeutics, Inc.

Patrimonio netto: 75 894 $ in data 29/02/2024

43 anni
Finance
Consumer Services
Health Technology

Profilo

Matthew Angel founded Factor Bioscience, Inc., Novellus LLC and Exacis Biotherapeutics, Inc. Presently, Dr. Angel is Director & Chief Scientific Officer at Exacis Biotherapeutics, Inc. In the past he held the position of Chairman, President & Chief Executive Officer for Factor Bioscience, Inc., President & Chief Executive Officer for Eterna Therapeutics, Inc. and Chief Science Officer at Novellus LLC (a subsidiary of Eterna Therapeutics, Inc.) and President, Chief Executive Officer & Director at Eterna Therapeutics, Inc. and Chief Science Officer at Novellus LLC (a subsidiary of Eterna Therapeutics, Inc.).
He received a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
26/04/2023 48 650 ( 0.90% ) 75 894 $ 29/02/2024

Posizioni attive di Matthew Angel

SocietàPosizioneInizio
Founder 01/01/2020
Tutte le posizioni attive di Matthew Angel

Precedenti posizioni note di Matthew Angel

SocietàPosizioneFine
ETERNA THERAPEUTICS INC. Chief Executive Officer 31/12/2023
ETERNA THERAPEUTICS INC. Chief Executive Officer 04/08/2023
Chief Executive Officer 01/01/2022
Founder 01/07/2021
Vedi nel dettaglio l'esperienza di Matthew Angel

Formazione di Matthew Angel

Massachusetts Institute of Technology Doctorate Degree
Princeton University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Matthew Angel

Relazioni

6

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private4

Health Technology

Commercial Services

Health Services

Eterna Therapeutics, Inc.

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Matthew Angel